Correlation Between Ascendis Pharma and Insmed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Insmed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Insmed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Insmed Inc, you can compare the effects of market volatilities on Ascendis Pharma and Insmed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Insmed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Insmed.

Diversification Opportunities for Ascendis Pharma and Insmed

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Ascendis and Insmed is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Insmed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insmed Inc and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Insmed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insmed Inc has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Insmed go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Insmed

Given the investment horizon of 90 days Ascendis Pharma AS is expected to generate 1.56 times more return on investment than Insmed. However, Ascendis Pharma is 1.56 times more volatile than Insmed Inc. It trades about 0.09 of its potential returns per unit of risk. Insmed Inc is currently generating about 0.1 per unit of risk. If you would invest  13,648  in Ascendis Pharma AS on December 29, 2024 and sell it today you would earn a total of  2,146  from holding Ascendis Pharma AS or generate 15.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ascendis Pharma AS  vs.  Insmed Inc

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Ascendis Pharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Insmed Inc 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Insmed Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Insmed displayed solid returns over the last few months and may actually be approaching a breakup point.

Ascendis Pharma and Insmed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and Insmed

The main advantage of trading using opposite Ascendis Pharma and Insmed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Insmed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insmed will offset losses from the drop in Insmed's long position.
The idea behind Ascendis Pharma AS and Insmed Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes